These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


105 related items for PubMed ID: 1145480

  • 1. [Clinical importance of determination of the products of decomposition of fibrin and fibrinogen in urine in patients with glomerulonephritis].
    Belitskaia GA, Ena IaM, Varetskaia TV, Tsynkalevskaia SN, Tsariuk LA.
    Ter Arkh; 1975; 47(4):46-50. PubMed ID: 1145480
    [No Abstract] [Full Text] [Related]

  • 2. Characterization and significance of urinary fibrin degradation products.
    Cortes P, Potter EV, Kwaan HC.
    J Lab Clin Med; 1973 Sep; 82(3):377-89. PubMed ID: 4199524
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Fibrin/fibrinogen degradation products in glomerulonephritis.
    Yatzidis H.
    Br Med J; 1971 Sep 25; 3(5777):767. PubMed ID: 5097978
    [No Abstract] [Full Text] [Related]

  • 6. Origin of urinary fibrin/fibrinogen degradation products in glomerulonephritis.
    Ekberg M, Pandolfi M.
    Br Med J; 1975 Apr 05; 2(5961):17-9. PubMed ID: 48398
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Urinary excretion of fibrinogen-fibrin-related antigen in glomerulonephritis: effect of indomethacin.
    Dotremont G, Vermylen J, Donati MB, Van Damme B, Michielsen P.
    Perspect Nephrol Hypertens; 1973 Apr 05; 1 Pt 2(0):829-44. PubMed ID: 4803317
    [No Abstract] [Full Text] [Related]

  • 12. [Clinical significance of urinary fibrin/fibrinogen degradation products in renal disease. First report: Urinary fibrin/fibrinogen degradation products in primary glomerulonephritis (author's transl)].
    Miyamura S.
    Nihon Jinzo Gakkai Shi; 1978 Jan 05; 20(1):67-78. PubMed ID: 650992
    [No Abstract] [Full Text] [Related]

  • 13. [Diagnostic value of determining urinary fibrin split products in glomerulonephritis, pyelonephritis and graft rejection].
    Schmitt E, Seyfarth M, Templin R, Schneider P, Klinkmann H.
    Z Urol Nephrol; 1978 Nov 05; 71(11):787-97. PubMed ID: 366978
    [Abstract] [Full Text] [Related]

  • 14. Modification by drugs of urinary fibrin/fibrinogen degradation products in glomerulonephritis.
    Clarkson AR, MacDonald MK, Cash JD, Robson JS.
    Br Med J; 1972 Jul 29; 3(5821):255-60. PubMed ID: 5046478
    [Abstract] [Full Text] [Related]

  • 15. [Blood coagulation and excretion of coagulation and fibrinolysis factors with urine of patients with diffuse glomerulonephritis].
    Zorina SS, Krasik IaD.
    Ter Arkh; 1974 Jul 29; 46(7):54-62. PubMed ID: 4408677
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Urinary fibrin-fibrinogen degradation products in nephrotic syndrome.
    Hall CL, Pejhan N, Terry JM, Blainey JD.
    Br Med J; 1975 Feb 22; 1(5955):419-22. PubMed ID: 803853
    [Abstract] [Full Text] [Related]

  • 19. Urinary fibrin split products in human renal disease.
    Stiehm ER, Kuplic LS, Uehling DT.
    J Lab Clin Med; 1971 May 22; 77(5):843-52. PubMed ID: 5557667
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.